Search clinical trials for: Liposomal paclitaxel plus capecitabine
Total 606 results
-
Sun Yat-sen UniversityUnknownNasopharyngeal Carcinoma | ChildrenChina
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerUnited States, Spain, United Kingdom, Korea, Republic of, Philippines, Canada, Germany, Italy, Poland, Belgium, Mexico, Japan, France, Brazil, Taiwan, Thailand, Hungary, Turkey, China, India, South Africa, Singapore, Argentina
-
Qilu Pharmaceutical Co., Ltd.Not yet recruiting
-
Sun Yat-sen UniversityRecruitingAngiosarcoma MetastaticChina
-
Damanhour UniversityCompleted
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Locally Advanced Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic Adenocarcinoma | Stage II Pancreatic Cancer AJCC v6 and v7 | Stage IIA Pancreatic Cancer AJCC v6 and v7 | Stage IIB Pancreatic Cancer AJCC v6 and...United States
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
Tesaro, Inc.Terminated
-
Fudan UniversityCompleted
-
Fudan UniversityNot yet recruitingAdvanced Pancreatic CancerChina
-
Nanjing Luye Sike Pharmaceutical Co., Ltd.Unknown
-
Swiss Group for Clinical Cancer ResearchCompletedPain | Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct CancerSwitzerland
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); United States Department of DefenseCompleted
-
Gruppo Oncologico del Nord-OvestRecruiting
-
Merck Sharp & Dohme LLCCompleted
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdNot yet recruiting
-
Tianjin Medical University Cancer Institute and...The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsUnknownEsophageal Cancer Stage III | Esophageal Cancer Stage IIBChina
-
Guangxi Medical UniversityWithdrawn
-
Shanghai General Hospital, Shanghai Jiao Tong University...Recruiting
-
Shandong Cancer Hospital and InstituteUnknownBreast Cancer | HER2-positive Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownTriple Negative Breast CancerChina
-
Athenex, Inc.PharmaEssentia; Zenith Technology Corporation LimitedCompletedSolid TumorNew Zealand, Taiwan, Australia
-
WiSP Wissenschaftlicher Service Pharma GmbHBristol-Myers Squibb; Roche Pharma AGCompleted
-
INSYS Therapeutics IncCompletedNeoplasmUnited States
-
Universitaire Ziekenhuizen KU LeuvenAstraZenecaActive, not recruitingOvarian Epithelial CancerBelgium
-
University of Michigan Rogel Cancer CenterCompletedUrothelial CarcinomaUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.TerminatedNeoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms | Primary Peritoneal NeoplasmUnited States
-
Shanghai Chest HospitalNot yet recruitingEsophageal Squamous Cell CarcinomaChina
-
Yuhong LiCompleted
-
Asan Medical CenterCompleted
-
Georgetown UniversityRecruitingNon-metastatic Breast Cancer | Cancer Related Cognitive DeclineUnited States
-
IRCCS San RaffaeleCompletedPancreatic CancerItaly
-
Fudan UniversityFujian Cancer Hospital; Affiliated Hospital of Jiangnan University; First Affiliated... and other collaboratorsCompletedEsophageal Squamous Cell CarcinomaChina
-
Peking UniversityUnknownChemotherapy Effect | Esophageal Cancer, Squamous Cell | Cetuximab EffectChina
-
National Cancer Institute (NCI)NRG OncologyWithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditionsUnited States
-
Beijing Tongren HospitalRecruitingHead and Neck Squamous Cell Carcinoma | Neoadjuvant Therapy | PembrolizumabChina
-
Walter Reed National Military Medical CenterCompletedPostoperative PainUnited States
-
Fujian Cancer HospitalUnknown
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.Active, not recruiting
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
INSYS Therapeutics IncCompleted
-
Ruijin HospitalRecruiting
-
Indiana University School of MedicineNovartisCompletedCarcinoma | Neoplasm MetastasisUnited States
-
AkesoCompletedLung Cancer Non-Small Cell Stage IIIB/IIIC/IVChina
-
Fundacion Investigacion Interhospitalaria CardiovascularEffice Servicios Para la Investigacion S.L.TerminatedAcute Myocardial InfarctionSpain
-
Peng LiuNot yet recruitingHistological or Cytological Confirmed Stage Ⅲ and Ⅳa ThymomaChina
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States